FIELD: medicine.
SUBSTANCE: composition comprises pancreatine as active ingredient, lactose, calcium stearate, filler and coating capsule soluble in intestine composed of acetylphthalyl cellulose, titanium dioxide, binding agent and acid red and sliding. Potato starch is used is used as filler. Nucleus additionally has sugar invention in 1 : (1.8-2) proportion to lactose, Copolyvidon. The coating capsule has polyethyleneoxide as binding agent.
EFFECT: high stability in acid medium; enhanced effectiveness of treatment.
4 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION USING IN PANCREAS DISEASES | 2002 |
|
RU2207847C1 |
FERESTAL POLYENZYMATIC PREPARATION | 2001 |
|
RU2201763C1 |
MEDICINAL AGENT FOR TREATMENT OF PATIENTS WITH DECREASED EXTERNALLY SECRETORY PANCREAS FUNCTION | 1994 |
|
RU2068698C1 |
PREPARATION FOR GASTROENTERIC ENZYMOPATHY TREATMENT | 1992 |
|
RU2057538C1 |
AGENT FOR TREATMENT OF PROSTATE DISEASE | 2005 |
|
RU2278681C1 |
SOLID PHARMACEUTICAL COMPOSITION AND METHOD OF ITS PREPARING | 2001 |
|
RU2200002C1 |
PHARMACEUTICAL COMPOSITION SHOWING INTERNAL EFFECT | 1999 |
|
RU2147878C1 |
PENTOXYPHYLLINE-BASE DRUG | 2001 |
|
RU2190408C1 |
DIINDOLYLMETHANE SOLID MEDICINAL FORMULATION FOR TREATMENT OF NEOPLASTIC DISEASE | 2006 |
|
RU2318509C2 |
LAXATIVE SOLID DOSAGE FORM AND METHOD FOR PREPARING THEREOF (VERSIONS) | 2009 |
|
RU2401106C1 |
Authors
Dates
2006-05-27—Published
2004-10-07—Filed